Skip to main content
Annovis Bio, Inc. (ANVS)
NYSE: ANVS · IEX Real-Time Price · USD
18.01
+4.41 (32.43%)
At close: Apr 26, 2024, 4:00 PM
17.90
-0.11 (-0.61%)
After-hours: Apr 26, 2024, 7:58 PM EDT

Annovis Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current20232022202120202019
Market Capitalization
19819211014252-
Market Cap Growth
-75.03%-23.01%174.06%--
Enterprise Value
1931868197440
PE Ratio
-3.41-3.41-4.33-9.83-9.51-
PB Ratio
-24.76-24.763.873.206.89-
P/FCF Ratio
-4.80-4.80-6.33-15.59-13.09-
P/OCF Ratio
-4.80-4.80-6.33-15.59-13.09-
EV/EBITDA Ratio
-3.31-3.31-3.21-6.68-8.04-0.48
EV/EBIT Ratio
-3.31-3.31-3.21-6.68-8.04-0.48
EV/FCF Ratio
-4.66-4.66-4.69-10.59-11.05-1.04
Debt / Equity Ratio
------0.06
Debt / EBITDA Ratio
------0.48
Debt / FCF Ratio
------1.05
Quick Ratio
1.341.343.6930.3313.960.37
Current Ratio
2.392.394.6830.5414.040.37
Return on Equity (ROE)
-565.10%-565.10%-74.70%-40.20%-59.30%12.30%
Return on Assets (ROA)
-326.80%-326.80%-68.30%-38.90%-55.80%-169.70%
Return on Capital (ROIC)
581.03%581.03%-90.07%-32.67%-88.06%19.88%
Earnings Yield
-28.34%-29.29%-23.10%-10.17%-10.51%-
FCF Yield
-20.15%-20.83%-15.79%-6.41%-7.64%-
Buyback Yield / Dilution
-10.55%-10.55%-7.03%-20.88%-2132.36%-1.81%
Total Shareholder Return
-10.55%-10.55%-7.03%-20.88%-2132.36%-1.81%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).